Smart Assays joins the fight against COVID-19 by developing assays for novel antiviral drugs.
Develop core R&D assets
Decipher a challenging MOA or POC
Decrease investment risk with hands-on validation
About Smart Assays
Smart Assays has been a key factor in the regulatory submissions and financing rounds of public and private life science companies providing hands-on expertise and tailor-made R&D services for evaluation and validation of early and clinical-stage projects.
Fields of Expertise
I have been working with Smart Assays from 2013 on 3 separate programs, as VP R&D and now COO in public and private companies. The first question Smart Assays asks is “What would you like to accomplish” and then they plan and perform an out-of-the-box strategy that gets you there via the shortest possible route. A great example of a hands-on, enterprising spirit that holds its own and deliver faster than larger R&D service providers.
Dori Pelled, Ph.D., COO, IMEL Biotherapeutics Inc.
News and Events